Apt Medical Inc. (688617.SH) plans to distribute 20 yuan per 10 shares and convert 4.5 shares on July 26th, 2023.
Apt Medical Inc. (688617.SH) announced the company's plan to distribute a cash dividend of RMB 1.0 (tax included) per 10 shares to all shareholders for the year 2023.
APT Medical Inc.'s (SHSE:688617) Stock Has Fared Decently: Is the Market Following Strong Financials?
Institutional Investors in APT Medical Inc. (SHSE:688617) See CN¥2.3b Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
Cathay Pacific Junan: The valuation level of the normalized mining industry is expected to rise
The Zhitong Finance App learned that Guotai Junan released a research report saying that in recent years, the quality of collection has been improved and expanded. Along with this, the design of collection rules has been continuously improved, and the results are more moderate and predictable. The results of this joint China Mining contract renewal have provided further verification. As the negative effects of traditional product collection are gradually clarified, emerging varieties are rapidly being admitted to hospital through collection. The number of surgeries is expected to continue to grow under the combined impetus of factors such as an aging population, increased public health awareness, and more mature procedures. The high-value consumables industry is also expected to continue to flourish on a new base, and the industry's valuation level is expected to rise. Maintain Elken Healthcare (0178
Some Shareholders Feeling Restless Over APT Medical Inc.'s (SHSE:688617) P/E Ratio
Mindray Healthcare (300760.SZ) obtains control of Huitai Healthcare
Mindray Healthcare (300760.SZ) announced that as of the date of this announcement, Cheng Zhenghui held Huitai Medical 1251.9...
Huitai Healthcare (688617.SH) announced first-quarter results, net profit of 140 million yuan, up 36.48% year-on-year
Huitai Healthcare (688617.SH) released its report for the first quarter of 2024. The company achieved operating income of 4 during the reporting period...
Huitai Medical (688617.SH)'s wholly-owned subsidiary obtained a medical device registration certificate
Huitai Medical (688617.SH) announced, April 19, 2024, Hunan Ept, a wholly-owned subsidiary of the company...
Calculating The Fair Value Of APT Medical Inc. (SHSE:688617)
Additional Considerations Required While Assessing APT Medical's (SHSE:688617) Strong Earnings
APT Medical's 2023 Profit Jumps 49%
Huitai Healthcare (688617.SH) released 2023 results, net profit of 534 million yuan, an increase of 49.13% year on year
Huitai Healthcare (688617.SH) released its 2023 annual report, achieving revenue of 1.65 billion yuan, with...
Investors Should Be Encouraged By APT Medical's (SHSE:688617) Returns On Capital
Huitai Healthcare (688617.SH) performance report: 2023 net profit of 536 million yuan increased 49.61% year-on-year
Gelonghui, Feb. 23 | Huitai Healthcare (688617.SH) announced the 2023 Annual Results Report. During the reporting period, the company achieved operating income of 1,651 million yuan, an increase of 35.79% over the same period of the previous year; net profit attributable to owners of the parent company was 536 million yuan, an increase of 49.61% over the same period last year; net profit attributable to owners of the parent company after deduction of non-recurring profit and loss was 475 million yuan, an increase of 47.64% over the same period last year.
Ping An Securities: Demand in the electrophysiology industry is strong, and there is plenty of room for domestic alternatives
The Zhitong Finance App learned that Ping An Securities released a research report saying that demand in the electrophysiology industry is strong, the number of surgeries is expected to maintain a rapid growth trend, and there is plenty of room for domestic alternatives. However, with microelectrophysiology high-density calibration catheters, pressure-sensing radiofrequency ablation catheters, microelectrophysiology, Kangfeng biological cryofrequency ablation systems, and the Jinjiang Electronic Pulse Field Ablation System successively obtained NMPA registration and listing, domestic production is about to break the market. It is recommended to focus on high-quality domestic manufacturers with perfect product layout and high equipment installed capacity, such as Microelectrophysiology (688351.SH) and Huitai Medical (688617.SH). Ping An Securities views such as
Institutional Investors Have a Lot Riding on APT Medical Inc. (SHSE:688617) With 37% Ownership
Is the healthcare market recovering? Mindray Healthcare acquires control of Whitney Healthcare at 25% premium | Insight Research
In the new year, A was born, and the leading device company Mindray entered the cardiovascular field at a premium.
Mindray Healthcare (300760.SZ): Proposed acquisition of a portion of Huitai Medical's shares, and its controlling shareholder will be changed to Shenzhen Control
Gelonghui, January 28 | Mindray Healthcare (300760.SZ) announced that on January 28, 2024, the wholly-owned subsidiary Shenmai Holdings and Cheng Zhenghui, Cheng Ling, Dai Zhenhua, Shanghai Huishen, Shanghai HuiHealth, Qihua Phase III, Qiming Rongying, QM33 (hereinafter collectively referred to as “Transferor 1”) signed a “Share Transfer Agreement” (hereinafter referred to as “Share Transfer Agreement 1”). Shenzhen Mai Holdings plans to transfer the price of 471.12 yuan/share held by the transferor 13,185,240 shares (accounting for the total share capital of the bid company 19.72%). simultaneously
Huitai Healthcare (688617.SH): 21.685,500 restricted shares listed and in circulation on February 2
Gelonghui, January 26丨Huitai Medical (688617.SH) announced that the sale restrictions have been lifted and the number of shares in circulation applying for listing is 21.6855 million shares. The sales restriction period is 36 months from the date of listing of the company's shares. The lockdown period has now expired and will be listed and distributed from February 2, 2024.
Subdued Growth No Barrier To APT Medical Inc.'s (SHSE:688617) Price
No Data